Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29951488 | 1.00 | CYP1A2 (0.38) | CYP1A2ALDH1A1MAPK1SMN1; SMN2KDM4E | |
| SCHEMBL17983436 | 0.79 | KDM4E (0.35) | CYP1A2ALDH1A1MAPK1SMN1; SMN2KDM4E | |
| SCHEMBL25083506 | 0.78 | ALDH1A1 (0.41) | CYP1A2ALDH1A1MAPK1SMN1; SMN2KDM4E | |
| SCHEMBL29957337 | 0.78 | ALDH1A1 (0.41) | CYP1A2ALDH1A1MAPK1SMN1; SMN2KDM4E | |
| SCHEMBL3175002 | 0.78 | NCF1 (0.37) | ALDH1A1MAPK1SMN1; SMN2KDM4EGAA | |
| SCHEMBL29951145 | 0.78 | NCF1 (0.37) | ALDH1A1MAPK1SMN1; SMN2KDM4EGAA | |
| SCHEMBL8328225 | 0.78 | BACE1 (0.41) | ALDH1A1ERN1 | |
| SCHEMBL11808695 | 0.78 | KDM4E (0.46) | CYP1A2ALDH1A1MAPK1SMN1; SMN2KDM4E | |
| SCHEMBL18823103 | 0.78 | ERN1 (0.33) | CYP1A2ALDH1A1KDM4EMAPTERN1 | |
| SCHEMBL29951247 | 0.78 | ALDH1A1 (0.50) | CYP1A2ALDH1A1MAPK1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737952-A1 | METHOD FOR PRODUCING LENS | Nikon-Essilor Co., Ltd. (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260118558-A1 | METHOD FOR PRODUCING LENS | NIKON-ESSILOR CO., LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4704849-A1 | LONG-ACTING COLLOIDAL PHARMACEUTICAL COMPOSITIONS OF INTEGRASE STRAND TRANSFER INHIBITORS AND RELATED METHODS | University of Washington (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260048066-A1 | TREATMENT OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS | WISTA LABORATORIES LTD (SG) | 2026-02-19 | — | — | US | disclosed |
| EP-3812428-B1 | COLLOIDAL STRUCTURE, MULTI-COLLOIDAL STRUCTURE, AND PRODUCTION METHOD FOR COLLOIDAL STRUCTURE | PANASONIC IP MAN CO LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| EP-4640920-A1 | INSULATION COATING FILM COMPOSITION FOR GRAIN-ORIENTED ELECTRICAL STEEL SHEET, PREPARATION METHOD THEREFOR, GRAIN-ORIENTED ELECTRICAL STEEL SHEET HAVING INSULATION COATING FILM FORMED ON SURFACE THEREOF BY USING SAME, AND MANUFACTURING METHOD THEREFOR | POSCO Co., Ltd (KR) | 2025-10-29 | — | — | EP | disclosed |
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| EP-4276162-B1 | CLEANING COMPOSITIONS CONTAINING BRANCHED ALKYL SULFATE SURFACTANTS AND LINEAR ALKYL SULFATE SURFACTANTS AND LINEAR ALKYLBENZENE SULPHONATES | PROCTER & GAMBLE (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-4335517-B1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LAB LTD (SG) | 2025-08-27 | — | — | EP | disclosed |
| US-20250262219-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2025-08-21 | — | — | US | disclosed |
| US-20220089974-A1 | LAUNDRY CARE COMPOSITIONS AND METHODS FOR DETERMINING THEIR AGE | PROCTER & GAMBLE (US) | 2022-03-24 | — | — | US | disclosed |
| US-11274267-B2 | Compositions containing an etheramine | THE PROCTER & GAMBLE COMPANY (US) | 2022-03-15 | — | — | US | disclosed |
| EP-3962645-A1 | MOLDING COMPRISING A TYPE MFI ZEOLITIC TITANOSILICATE AND A SILICA BINDER, ITS PREPARATION PROCESS AND USE AS CATALYST | BASF SE (DE) | 2022-03-09 | — | — | EP | disclosed |
| US-11268047-B2 | Compositions containing an etheramine | THE PROCTER & GAMBLE COMPANY (US) | 2022-03-08 | — | — | US | disclosed |
| US-20220056380-A1 | CLEANING COMPOSITION | THE PROCTER AND GAMBLE COMPANY | 2022-02-24 | — | — | US | disclosed |
| US-11230686-B2 | Laundry care compositions and methods for determining their age | THE PROCTER & GAMBLE COMPANY (US) | 2022-01-25 | — | — | US | disclosed |
| EP-1178969-B1 | GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | BLACK JAMES FOUNDATION (GB) | 2005-07-13 | — | — | EP | disclosed |
| US-6479531-B1 | Gastrin and cholecystokinin receptor ligands | JAMES BLACK FOUNDATION LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| EP-1178969-A1 | GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | JAMES BLACK FOUNDATION LIMITED (GB) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000027823-A1 | GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | JAMES BLACK FOUNDATION LIMITED (GB) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | PSEN1, PSEN2, APP | CYP1A2 533/4885ALDH1A1 2648/4885MAPK1 2122/4885 |
| US-20260048066-A1 | TREATMENT OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS | MAPT, PARK7, TARDBP | CYP1A2 3345/4885ALDH1A1 4715/4885MAPK1 3344/4885 |
| US-20260118558-A1 | METHOD FOR PRODUCING LENS | CNN2, MAP1LC3C, MAP1LC3A | CYP1A2 1761/4885ALDH1A1 2338/4885MAPK1 1742/4885 |
| US-20250262219-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | ACHE, BCHE, PNMT | CYP1A2 605/4885ALDH1A1 2054/4885MAPK1 2738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.